In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trial Results

Summaries of Newsworthy Clinical Trial Results < Back to Main

Page Options

  • Print This Page
  • Email This Document

Search Trial Results

Related Pages

Breast Cancer Trial Results

Extra Fruits and Vegetables Don't Cut Risk of Further Breast Cancer: Results of the WHEL Study
(Posted: 09/26/2007) - In the WHEL study, a diet high in fruits, vegetables, and fiber and somewhat lower in fat did not protect early-stage breast cancer survivors from further breast cancer, nor did it help them live longer, according to the July 18, 2007, Journal of the American Medical Association.

Hypnosis Before Breast-Cancer Surgery Reduces Pain, Discomfort, and Cost
(Posted: 09/12/2007) - Women undergoing surgery for breast cancer who received hypnosis before entering the operating room required less anesthesia and pain medication during surgery, and reported less pain, nausea, fatigue, and discomfort after surgery than women who did not receive hypnosis, according to the Sept. 5, 2007, Journal of the National Cancer Institute.

Boost Radiation Beneficial in Early-Stage Breast Cancer
(Posted: 07/11/2007) - In women with early-stage breast cancer who had been treated with breast-conserving lumpectomy and radiation, an additional "boost" dose of radiation to the original tumor site reduced the risk of cancer coming back in the same breast, though it did not help them live longer, according to the Aug. 1, 2007, Journal of Clinical Oncology.

Ovary-Suppressing Drugs Can Prevent Return of Breast Cancer
(Posted: 06/25/2007) - In premenopausal women with hormone-sensitive breast cancer, drugs that stop the ovaries from functioning - thus shutting off the body's main source of the hormone estrogen - reduced the rates of relapse and of death following relapse when given in addition to tamoxifen, chemotherapy, or both, according to the May 19, 2007, Lancet.

Studies Affirm Tamoxifen's Long-Term Preventive Benefit
(Posted: 03/07/2007) - Long-term follow-up data from two cancer prevention trials have confirmed that women at high risk for breast cancer continue to receive a risk-reduction benefit from tamoxifen years after they have stopped taking it, according to the Feb. 21, 2007, Journal of the National Cancer Institute.

< Previous  1 2 3 4 5 6 7 8 9 10  Next >